{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:00:07Z","timestamp":1787500807644,"version":"build-2736575974"},"reference-count":40,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","award":["CHF-SPONS-00147"],"award-info":[{"award-number":["CHF-SPONS-00147"]}],"id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2021,9,12]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in people with cystic fibrosis (pwCF) can lead to severe outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this observational study, the European Cystic Fibrosis Society Patient Registry collected data on pwCF and SARS-CoV-2 infection to estimate incidence, describe clinical presentation and investigate factors associated with severe outcomes using multivariable analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Up to December 31, 2020, 26 countries reported information on 828 pwCF and SARS-CoV-2 infection. Incidence was 17.2 per 1000 pwCF (95% CI: 16.0\u201318.4). Median age was 24\u2005years, 48.4% were male and 9.4% had lung transplants. SARS-CoV-2 incidence was higher in lung-transplanted (28.6; 95% CI: 22.7\u201335.5)\n                      <jats:italic>versus<\/jats:italic>\n                      non-lung-transplanted pwCF (16.6; 95% CI: 15.4\u201317.8) (p\u22640.001).\n                    <\/jats:p>\n                    <jats:p>SARS-CoV-2 infection caused symptomatic illness in 75.7%. Factors associated with symptomatic SARS-CoV-2 infection were age &gt;40\u2005years, at least one F508del mutation and pancreatic insufficiency.<\/jats:p>\n                    <jats:p>\n                      Overall, 23.7% of pwCF were admitted to hospital, 2.5% of those to intensive care, and regretfully 11 (1.4%) died. Hospitalisation, oxygen therapy, intensive care, respiratory support and death were 2- to 6-fold more frequent in lung-transplanted\n                      <jats:italic>versus<\/jats:italic>\n                      non-lung-transplanted pwCF.\n                    <\/jats:p>\n                    <jats:p>\n                      Factors associated with hospitalisation and oxygen therapy were lung transplantation, cystic fibrosis-related diabetes (CFRD), moderate or severe lung disease and azithromycin use (often considered a surrogate marker for\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      infection and poorer lung function).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SARS-CoV-2 infection yielded high morbidity and hospitalisation in pwCF. PwCF with forced expiratory volume in 1\u2005s &lt;70% predicted, CFRD and those with lung transplants are at particular risk of more severe outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.00411-2021","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T11:51:09Z","timestamp":1635421869000},"page":"00411-2021","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe"],"prefix":"10.1183","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-6691","authenticated-orcid":false,"given":"Andreas","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0932-2757","authenticated-orcid":false,"given":"Annalisa","family":"Orenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Dunlevy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Aleksejeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egil","family":"Bakkeheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Bobrovnichy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0580-2478","authenticated-orcid":false,"given":"Siobh\u00e1n B.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7026-7523","authenticated-orcid":false,"given":"Harriet","family":"Corvol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cosgriff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2570-0893","authenticated-orcid":false,"given":"G\u00e9raldine","family":"Daneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9931-9473","authenticated-orcid":false,"given":"Deniz","family":"Dogru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Drevinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Dugac","family":"Vukic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Fajac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stojka","family":"Fustik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Gulmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satenik","family":"Harutyunyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elpis","family":"Hatziagorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Kasmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Kayserov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kondratyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9031-5708","authenticated-orcid":false,"given":"Uro\u0161","family":"Krivec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halyna","family":"Makukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kestutis","family":"Malakauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"McKone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Mei-Zahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"de Monestrol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne Vebert","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-7940","authenticated-orcid":false,"given":"Tsitsino","family":"Parulava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8917-4709","authenticated-orcid":false,"given":"Maria Dolores","family":"Pastor-Vivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00edsa","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guergana","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pfleger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liviu","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqui G.","family":"van Rens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Rodic\u00b4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schlesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9344-0248","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Storms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oxana","family":"Turcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Woz\u00b4niacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis","family":"Yiallouros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian G.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Naehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"2024101711241642000_7.4.00411-2021.1","unstructured":"World Health Organisation . Weekly epidemiological update \u2013 29 December 2020. www.who.int\/publications\/m\/item\/weekly-epidemiological-update---29-december-2020 Date last updated: 29 December 2020. Date last accessed: 23 March 2021."},{"key":"2024101711241642000_7.4.00411-2021.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2011.06.004"},{"key":"2024101711241642000_7.4.00411-2021.3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03067"},{"key":"2024101711241642000_7.4.00411-2021.4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jcf.2020.04.011","article-title":"Influenza B outbreak at an adult cystic fibrosis centre: clinical impact and factors influencing spread","volume":"19","author":"Dennis","year":"2020","journal-title":"J Cyst Fibros"},{"key":"2024101711241642000_7.4.00411-2021.5","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S2213-2600(20)30177-6","article-title":"Impact of COVID-19 on people with cystic fibrosis","volume":"8","author":"Colombo","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024101711241642000_7.4.00411-2021.6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02114-2020"},{"key":"2024101711241642000_7.4.00411-2021.7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jcf.2021.03.017","article-title":"Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020","volume":"20","author":"Naerlich L,","year":"2021","journal-title":"J Cyst Fibros"},{"key":"2024101711241642000_7.4.00411-2021.8","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jcf.2020.10.003","article-title":"The global impact of SARS-CoV-2 in 181 people with cystic fibrosis","volume":"19","author":"McClenaghan","year":"2020","journal-title":"J Cyst Fibros"},{"key":"2024101711241642000_7.4.00411-2021.9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcf.2020.11.021","article-title":"Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: an international observational study","volume":"20","author":"Bain","year":"2021","journal-title":"J Cyst Fibros"},{"key":"2024101711241642000_7.4.00411-2021.10","doi-asserted-by":"crossref","first-page":"106062","DOI":"10.1016\/j.rmed.2020.106062","article-title":"Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: incidence and results of the national CF-COVID19-Spain survey","volume":"170","author":"Mondejar-Lopez","year":"2020","journal-title":"Respir Med"},{"key":"2024101711241642000_7.4.00411-2021.11","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.3390\/jcm9113624","article-title":"First wave of COVID-19 in French patients with cystic fibrosis","volume":"9","author":"Corvol","year":"2020","journal-title":"J Clin Med"},{"key":"2024101711241642000_7.4.00411-2021.12","first-page":"S1569","article-title":"First and second wave of SARS-CoV2 in Italian cystic fibrosis patients: data from Italian cystic fibrosis registry","volume":"26","author":"Padoan","year":"2021","journal-title":"J Cyst Fibros"},{"key":"2024101711241642000_7.4.00411-2021.13","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00035205"},{"key":"2024101711241642000_7.4.00411-2021.14","unstructured":"Zolin A , Orenti A , Naehrlich L , et al. ECFS Patient Registry Annual Report 2018. www.ecfs.eu\/projects\/ecfs-patient-registry\/annual-reports Date last updated: 2020. Date last accessed: 26 November 2021."},{"key":"2024101711241642000_7.4.00411-2021.15","unstructured":"Zolin A , Orenti A , Naehrlich L , et al. ECFS Patient Registry Annual Report 2017. www.ecfs.eu\/projects\/ecfs-patient-registry\/annual-reports Date last updated: 2019. Date last accessed: 26 November 2021."},{"key":"2024101711241642000_7.4.00411-2021.16","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwk052"},{"key":"2024101711241642000_7.4.00411-2021.17","unstructured":"European Centre for Disease Control . Data on testing for COVID-19 by week and country. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/covid-19-testing Date last updated: 25 November 2021. Date last accessed: 26 November 2021."},{"key":"2024101711241642000_7.4.00411-2021.18","unstructured":"International Society of Heart and Lung Transplantation (ISHLT) . Guidance from the International Society of Heart and Lung Transplantation regarding the SARS CoV-2 pandemic. https:\/\/ishlt.org\/ishlt\/media\/documents\/SARS-CoV-2_Guidance-for-Cardiothoracic-Transplant-and-VAD-center.pdf Date last updated: 1 February 2021. Date last accessed: 31 March 2021."},{"key":"2024101711241642000_7.4.00411-2021.19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003346"},{"key":"2024101711241642000_7.4.00411-2021.20","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.mayocp.2020.05.030","article-title":"Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis","volume":"95","author":"Agyeman","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"2024101711241642000_7.4.00411-2021.21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00405-012-2124-2","article-title":"Smell in cystic fibrosis","volume":"270","author":"Lindig","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2024101711241642000_7.4.00411-2021.22","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S2213-2600(21)00101-6","article-title":"Major differences in ICU admissions during the first and second COVID-19 wave in Germany","volume":"9","author":"Karagiannidis","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024101711241642000_7.4.00411-2021.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00048-2021"},{"key":"2024101711241642000_7.4.00411-2021.24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41435-020-0103-y","article-title":"COVID-19 meets Cystic Fibrosis: for better or worse?","volume":"21","author":"Peckham","year":"2020","journal-title":"Genes Immun"},{"key":"2024101711241642000_7.4.00411-2021.25","unstructured":"Centers for Disease Control and Prevention (CDC) . Evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID-19. www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/evidence-table.html Date last updated: 29 March 2021. Date last accessed: 22 December 2020."},{"key":"2024101711241642000_7.4.00411-2021.26","doi-asserted-by":"crossref","first-page":"100588","DOI":"10.1016\/j.trre.2020.100588","article-title":"COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature","volume":"35","author":"Raja","year":"2021","journal-title":"Transplant Rev (Orlando)"},{"key":"2024101711241642000_7.4.00411-2021.27","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/ajt.16364","article-title":"COVID-19 in lung transplant recipients: a multicenter study","volume":"21","author":"Saez-Gimenez","year":"2020","journal-title":"Am J Transplant"},{"key":"2024101711241642000_7.4.00411-2021.28","doi-asserted-by":"crossref","unstructured":"Kapriniotis K , Giannis D , Geropoulos G , et al. Heart and lung transplantation in the Era of COVID-19: early recommendations and outcomes. Exp Clin Transplant 2021; in press [https:\/\/10.6002\/ect.2020.0289].","DOI":"10.6002\/ect.2020.0289"},{"key":"2024101711241642000_7.4.00411-2021.29","unstructured":"International Society of Heart and Lung Transplantation (ISHLT) . SARS-CoV-2 Vaccination in Heart and Lung Transplantation: Recommendations from the ISHLT COVID-19 Task Force. https:\/\/ishlt.org\/ishlt\/media\/Documents\/COVID19_Vaccine-Recommendations_3-15-2021.pdf Date last updated: 15 March 2021. Date last accessed: 31 March 2021."},{"key":"2024101711241642000_7.4.00411-2021.30","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00149-5"},{"key":"2024101711241642000_7.4.00411-2021.31","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.1.57-71.2004"},{"key":"2024101711241642000_7.4.00411-2021.32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cyst Fibros"},{"key":"2024101711241642000_7.4.00411-2021.33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1164\/rccm.201906-1206OC","article-title":"Pulmonary outcomes associated with long-term azithromycin therapy in cystic fibrosis","volume":"201","author":"Nichols","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711241642000_7.4.00411-2021.34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S2213-8587(20)30405-8","article-title":"Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland","volume":"9","author":"McGurnaghan","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024101711241642000_7.4.00411-2021.35","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/dme.13652","article-title":"Unique challenges of cystic fibrosis-related diabetes","volume":"35","author":"Bridges","year":"2018","journal-title":"Diabet Med"},{"key":"2024101711241642000_7.4.00411-2021.36","first-page":"100253","article-title":"Managing Cystic Fibrosis related diabetes via telehealth during COVID-19 pandemic","volume":"23","author":"Hasan","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"key":"2024101711241642000_7.4.00411-2021.37","doi-asserted-by":"crossref","first-page":"e0247461","DOI":"10.1371\/journal.pone.0247461","article-title":"Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis","volume":"16","author":"Booth","year":"2021","journal-title":"PLoS ONE"},{"key":"2024101711241642000_7.4.00411-2021.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19741-6"},{"key":"2024101711241642000_7.4.00411-2021.39","doi-asserted-by":"crossref","first-page":"00475","DOI":"10.1183\/23120541.00475-2020","article-title":"Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes","volume":"7","author":"Lam","year":"2021","journal-title":"ERJ Open Res"},{"key":"2024101711241642000_7.4.00411-2021.40","unstructured":"Kuczmarski RJ , Ogden CL , Guo SS , et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002; 246: 1\u2013190."}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00411-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:12:51Z","timestamp":1740355971000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00411-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,12,27]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1183\/23120541.00411-2021"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00411-2021","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}